#AUA14 - Poster: Long-term efficacy and safety of repeat onabotulinumtoxinA treatment in overactive bladder syndrome and urinary incontinence: Third interim analysis, median 2.4 years follow-up

ORLANDO, FL USA (UroToday.com) - Presented by Victor Nitti,1 Christopher Chapple,2 David Sussman,3 Sidney Radomski,4 Peter Sand,5 Steven Guard,6 Christopher Nardo,7 Jihao Zhou,8 and Karl-Dietrich Sievert9 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

aua 2014 poster nitti oab es qol thumb

1New York University, New York, NY, USA; 2Royal Hallamshire Hospital, Sheffield, UK; 3NJ School of Osteopathic Medicine, Newark, NJ, USA; 4University of Toronto, Toronto, ON, Canada; 5University of Chicago, Chicago, IL, USA; 6Allergan, Ltd., Marlow, UK; 7Allergan, Inc., Irvine, CA, USA; 8Allergan, Inc., Bridgewater, NJ, USA; 9University of Tuebingen, Tuebingen, Germany

 

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Virtual Congress / September 19-21
  • 2020 BCAN Think Tank Virtual / August 7
  • 2020 Virtual Education Program / August 8-10
  • 2020 Annual Meeting / July 17-19 / EAU Virtual Program
  • SUO - AUA 2020 Summer Webcast / July 18
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Annual Meeting / October 3 - October 5 / Aarhus, Denmark
  • 2019 Annual Congress / September 27 - October 1 / Barcelona, Spain
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland